Breaking Down Tiandi Science & Technology Co.Ltd Financial Health: Key Insights for Investors

Curious whether Tiandi Science & Technology Co. Ltd (600582.SS) is a value play or a risk-laden holding? In Q3 2025 the company reported revenue of CNY 6.35 billion (down 10.51% YoY) and year-to-date revenue of CNY 20.47 billion (down 6.90%), while TTM revenue sits at CNY 29.01 billion (-3.33% YoY) amid pressure from lower coal prices and equipment competition; profitability shows a sharp Q3 net profit drop to CNY 260.06 million (-59.57% YoY) but YTD net profit of CNY 2.34 billion (+7.55% YoY) with TTM net profit margin of 9.6%, EPS of CNY 0.67 and a trailing P/E around 8; balance-sheet and liquidity metrics include total debt of CNY 838.45 million (debt/equity 0.03), net cash of CNY 8.32 billion, cash & equivalents of CNY 9.16 billion, operating cash flow TTM of CNY 4.31 billion and free cash flow of CNY 3.68 billion, yet credit signals such as an Altman Z‑Score of 1.9 and Piotroski F‑Score of 5 coexist with a dividend yield of 5.40%, trailing P/S of 0.86, P/B of 0.79 and a market cap near CNY 24.58 billion, so dive into the full breakdown to parse valuation, solvency, and the key risks versus growth angles investors need to weigh

Tiandi Science & Technology Co.Ltd (600582.SS) - Revenue Analysis

Tiandi Science & Technology Co.Ltd reported softer top-line performance through 2024-2025, reflecting sector pressures from falling coal prices and heightened competition in equipment manufacturing. Key reported figures and trends are summarized below.

• Q3 2025 revenue: CNY 6.35 billion (down 10.51% YoY).
• YTD 2025 revenue: CNY 20.47 billion (down 6.90% vs. YTD 2024).
• TTM revenue: CNY 29.01 billion (down 3.33% YoY).
• Full-year 2024 revenue: CNY 30.53 billion (up 2.00% vs. 2023).
• Market capitalization (as of 2025-12-12): ~CNY 24.29 billion.

Revenue drivers and headwinds:

• Commodity exposure: Lower coal prices directly compress revenues from mining-related sales and downstream demand.
• Competitive pressure: Equipment manufacturing faces margin and market-share erosion due to intensified competition and price concessions.
• Timing effects: YoY comps show a modest recovery in 2024 (+2.00%) followed by renewed weakness through 2025 (TTM -3.33%).
• Scale vs. valuation: Market cap (~CNY 24.29bn) implies investor pricing that may reflect earnings risk and capitalization of medium-term margin pressure.

For further context on ownership, institutional interest and investor behavior related to Tiandi Science & Technology Co.Ltd, see: Exploring Tiandi Science & Technology Co.Ltd Investor Profile: Who's Buying and Why?

Tiandi Science & Technology Co.Ltd (600582.SS) - Profitability Metrics

The following key profitability figures provide a snapshot of Tiandi Science & Technology Co.Ltd's recent earnings performance and returns to shareholders.

• Q3 2025 net profit attributable to shareholders: CNY 260.06 million (down 59.57% YoY).
• Year-to-date (2025) net profit: CNY 2.34 billion (up 7.55% vs. same period 2024).
• TTM net profit: CNY 2.79 billion; TTM net profit margin: 9.6%.
• Return on equity (ROE): 15.74%.
• TTM earnings per share (EPS): CNY 0.67; trailing P/E: 8.73.
• Dividend: CNY 0.32 per share annually; dividend yield: 5.40%.

For corporate purpose, strategy and long-term orientation, see: Mission Statement, Vision, & Core Values (2026) of Tiandi Science & Technology Co.Ltd.

Tiandi Science & Technology Co.Ltd (600582.SS) - Debt vs. Equity Structure

• Leverage: With a debt-to-equity of 0.03, equity provides the dominant funding source, reducing insolvency risk from high financial leverage.
• Liquidity: Current ratio 1.43 and quick ratio 1.08 indicate working capital is adequate to handle near-term obligations without relying on additional financing.
• Interest burden: An interest coverage ratio of 183.49 implies interest costs are negligible relative to operating income, giving flexibility for reinvestment or dividend policy.

• Early-warning signals: The Altman Z-Score of 1.9 is below typical 'safe' thresholds (often cited ~3.0), suggesting solvency stress potential despite low nominal debt-this may reflect weak profitability, asset structure, or prior losses.
• Operational quality: A Piotroski F-Score of 5 is middling, indicating some improvement areas in profitability, efficiency, or conservative accounting that investors should monitor.

Tiandi Science & Technology Co.Ltd (600582.SS) - Liquidity and Solvency

• Net cash position: CNY 8.32 billion
• Cash & cash equivalents: CNY 9.16 billion
• Operating cash flow (TTM): CNY 4.31 billion
• Capital expenditures (TTM): CNY 625.35 million
• Free cash flow (TTM): CNY 3.68 billion
• Income tax payments (past 12 months): CNY 1.02 billion
• Effective tax rate: 17.16%
• Equity beta: 0.45 (lower volatility vs. market)

• Capital efficiency: Operating cash flow covers capital expenditures by better than seven times, leaving substantial discretionary cash for buybacks, dividends, debt reduction, or strategic investments.
• Cash conversion: The high operating cash relative to net income signals an efficient cash conversion cycle and strong working capital management.
• Tax and cash outflows: With CNY 1.02 billion paid in income taxes and an effective tax rate of 17.16%, tax expense is a modest and predictable cash outflow relative to cash generation.
• Volatility and solvency risk: A beta of 0.45 suggests lower market-driven volatility, which combined with an 8.32 billion net cash cushion reduces solvency risk under stress scenarios.

Tiandi Science & Technology Co.Ltd (600582.SS) - Valuation Analysis

Key market and valuation metrics for Tiandi Science & Technology Co.Ltd (600582.SS) point toward an attractively priced equity on several standard measures, though some momentum indicators suggest caution.

• Trailing P/E: 7.65
• Forward P/E: 8.18
• Price-to-Sales (P/S): 0.86
• Price-to-Book (P/B): 0.79
• EV/Revenue: 0.80
• EV/EBITDA: 6.46

Practical investor takeaways:

• Valuation multiples (P/E, P/S, P/B, EV multiples) imply potential undervaluation versus peers and market averages.
• EV/EBITDA of 6.46 suggests a reasonable enterprise-level entry multiple for cash-flow-focused buyers.
• RSI at 70.88 flags possible short-term overbought conditions despite attractive fundamental multiples.
• Market cap decline of 3.10% year-over-year paired with a modest 52-week price gain (+1.78%) indicates limited market appreciation despite low multiples.

For background on corporate strategy, ownership and business model context that affect valuation, see: Tiandi Science & Technology Co.Ltd: History, Ownership, Mission, How It Works & Makes Money

Tiandi Science & Technology Co.Ltd (600582.SS) - Risk Factors

Recent operating and financial metrics for Tiandi Science & Technology Co.Ltd (600582.SS) point to a mix of stability and vulnerability. Investors should weigh declining top- and bottom-line trends alongside generally low leverage and muted market volatility.

• Revenue and net profit have declined in recent quarters, signaling operational or demand-side challenges that may pressure margins and cash flow.
• The Altman Z-Score stands at 1.9, below safe thresholds and indicating a higher bankruptcy risk relative to healthier peers.
• Market beta is 0.45, suggesting lower historical volatility versus the market, but this does not immunize the company from macroeconomic shocks or sector-specific disruptions.
• Piotroski F-Score is 5, reflecting middling financial quality - some positive signals but also areas requiring improvement in profitability, efficiency, or liquidity.
• Debt-to-equity ratio is 0.03, indicating very low leverage; while conservative debt levels reduce solvency risk, dependence on external financing or a sudden need for capital could still create vulnerability.
• Effective tax rate of 17.16% with income tax payments of CNY 1.02 billion materially affect net earnings and free cash flow available for reinvestment or shareholder returns.

• Operational risk: continued revenue and profit declines could force cost-cutting, affect R&D or capex, and weaken competitive position.
• Credit/solvency risk: Altman Z-Score near 1.9 warrants monitoring liquidity ratios, covenant exposure, and short-term refinancing needs despite low reported leverage.
• Market risk: low beta reduces price swings in normal markets but not protection against systemic shocks, regulatory changes, or sector downturns.
• Profitability pressure: the combination of middling Piotroski score and meaningful tax burden (17.16% tax rate; CNY 1.02B paid) constrains net margin recovery.
• Capital structure risk: minimal debt is positive for interest burden, yet reliance on equity or internal cash for future investments could limit growth initiatives.

For additional context on ownership, recent trading and investor composition see: Exploring Tiandi Science & Technology Co.Ltd Investor Profile: Who's Buying and Why?

Tiandi Science & Technology Co.Ltd (600582.SS) - Growth Opportunities

• Market capitalization: CNY 24.58 billion - a scale that supports continued investment in R&D, production capacity and M&A to capture market share.
• Valuation multiples suggest potential undervaluation: trailing P/E 7.65, forward P/E 8.18, P/S 0.86, P/B 0.79.
• Enterprise value metrics indicate attractive entry points: EV/Revenue 0.80 and EV/EBITDA 6.46.
• Robust cash generation: operating cash flow CNY 4.31 billion and free cash flow CNY 3.68 billion, with OCF covering capital expenditures by more than 7x, enabling reinvestment without heavy external financing.

• Growth levers: strong cash flow supports accelerated R&D, capacity expansion and selective M&A to broaden product mix and geographic reach.
• Margin upside: current EV/EBITDA of 6.46 implies room for multiple expansion if EBITDA margins improve via efficiency gains or higher-margin product mix.
• Balance-sheet resilience: low relative valuation (P/S 0.86, P/B 0.79) combined with sizable free cash flow creates a defensive position during market volatility and enables strategic capital deployments.